Discovery of Potential Therapeutic miRNA Targets in Cardiac Ischemia-Reperfusion Injury

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 21, Issue 3, 2016, Pages 296-309

  Zhou, Yue ^a   Chen, Qiying ^b   Lew, Kar Sheng ^a   Richards, A Mark ^a,c   Wang, Peipei ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

apoptosis; autophagy; cardioprotection; ischemia reperfusion (I R); microRNA (miRNA); therapeutic target

Indexed keywords

BIM PROTEIN; CASPASE 3; CASPASE 7; MICRORNA; MICRORNA 150; MICRORNA 206; MICRORNA 221; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; PEPTIDES AND PROTEINS; PHOSPHOPROTEIN; PROTECTIVE AGENT; PROTEIN BAK1; PROTEIN BMF; PROTEIN DDIT4; PROTEIN P27; PROTEIN TP53INP1; PUMA PROTEIN; RNA INDUCED SILENCING COMPLEX; SODIUM HYDROSULFIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UROCORTIN II; APOPTOSIS REGULATORY PROTEIN; MIRN150 MICRORNA, RAT; MIRN206 MICRORNA, RAT; MIRN221 MICRORNA, RAT; SODIUM BISULFIDE; SULFIDE; UROCORTIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHAGY; BAK1 GENE; CELL PROTECTION; CONTROLLED STUDY; DDIT4 GENE; DOWN REGULATION; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME RELEASE; FEASIBILITY STUDY; GENE CONTROL; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; MALE; NEWBORN; NONHUMAN; P27 GENE; PRIORITY JOURNAL; PUMA GENE; RAT; REPERFUSION INJURY; RNA ANALYSIS; TP53INP1 GENE; UPREGULATION; ANIMAL; CARDIAC MUSCLE CELL; CELL LINE; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; ISOLATED HEART; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC THERAPY; ISOLATED HEART PREPARATION; MALE; MICRORNAS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS, SPRAGUE-DAWLEY; SULFIDES; TRANSFECTION; UROCORTINS;

EID: 84963682704     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248415604463     Document Type: Article

References (45)

1. Lee RC, Feinbaum RL, Ambros V,. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75 (5): 843-854.
2. van Rooij E,. Introduction to the series on microRNAs in the cardiovascular system. Circ Res. 2012; 110 (3): 481-482.
3. Pillai RS, Bhattacharyya SN, Artus CG, et al. Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science. 2005; 309 (5740): 1573-1576.
4. Wu L, Fan J, Belasco JG,. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A. 2006; 103 (11): 4034-4039.
5. Perron MP, Provost P,. Protein interactions and complexes in human microRNA biogenesis and function. Front Biosci. 2008; 13 (11): 2537-2547.
6. Abdellatif M,. Differential expression of microRNAs in different disease states. Circ Res. 2012; 110 (4): 638-650.
7. Sala V, Bergerone S, Gatti S, et al. MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. Cell Mol Life Sci. 2014; 71 (8): 1439-1452.
8. Sha D, Lee AM, Shi Q, et al. Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial). Clin Cancer Res. 2014; 20 (12): 3319-3327.
9. Wahlquist C, Jeong D, Rojas-Munoz A, et al. Inhibition of miR-25 improves cardiac contractility in the failing heart. Nature. 2014; 508 (7497): 531-535.
10. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007; 13 (5): 613-618.
11. Matkovich SJ, Wang W, Tu Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res. 2010; 106 (1): 166-175.
12. D'Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010; 31: 2765-2773.
13. Yang B, Lin H, Xiao J, et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med. 2007; 13 (4): 486-491.
14. Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem. 2009; 284 (43): 29514-29525.
15. Sayed D, He M, Hong C, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010; 285 (26): 20281-20290.
16. Wang P, Lloyd SG, Chatham JC,. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation. 2005; 111 (16): 2066-2072.
17. Nagy T, Champattanachai V, Marchase RB, Chatham JC,. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. Am J Physiol Cell Physiol. 2006; 290 (1): C57-C65.
18. Esumi K, Nishida M, Shaw D, Smith TW, Marsh JD,. NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol. 1991; 260 (6 pt 2): H1743-1752.
19. Cory AH, Owen TC, Barltrop JA, Cory JG,. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun. 1991; 3 (7): 207-212.
20. Fotakis G, Timbrell JA,. In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett. 2006; 160 (2): 171-177.
21. Dueck A, Ziegler C, Eichner A, Berezikov E, Meister G,. microRNAs associated with the different human Argonaute proteins. Nucleic Acids Res. 2012; 40 (19): 9850-9862.
22. Zhou Y, Wang D, Gao X, Lew K, Richards AM, Wang P,. mTORC2 phosphorylation of Akt1: a possible mechanism for hydrogen sulfide-induced cardioprotection. PLoS One. 2014; 9 (6): e99665.
23. Gao XF, Zhou Y, Wang DY, Lew KS, Richards AM, Wang P,. Urocortin-2 suppression of p38-MAPK signaling as an additional mechanism for ischemic cardioprotection. Mol Cell Biochem. 2015; 398 (1-2): 135-146.
24. van Rooij E, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103 (48): 18255-18260.
25. Zhao Y, Ransom JF, Li A, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007; 129 (2): 303-317.
26. Lu Y, Zhang Y, Shan H, et al. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc Res. 2009; 84 (3): 434-441.
27. Zhu W, Yang L, Shan H, et al. MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction. PLoS One. 2011; 6 (2): e14736.
28. Townsend PA, Davidson SM, Clarke SJ, et al. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress. Am J Physiol Heart Circ Physiol. 2007; 293 (2): H928-938.
29. Brar BK, Jonassen AK, Stephanou A, et al. Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem. 2000; 275 (12): 8508-8514.
30. Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D,. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med. 2011; 208 (3): 549-560.
31. Ye Y, Hu Z, Lin Y, Zhang C, Perez-Polo JR,. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2010; 87 (3): 535-544.
32. Xiao J, Zhu X, He B, et al. MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II. J Biomed Sci. 2011; 18: 35.
33. Thomson DW, Bracken CP, Szubert JM, Goodall GJ,. On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PLoS One. 2013; 8 (1): e55214.
34. Hu S, Huang M, Nguyen PK, et al. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation. 2011; 124 (11 suppl): S27-S34.
35. Zhao G, Cai C, Yang T, et al. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One. 2013; 8 (1): e53906.
36. Liu X, Cheng Y, Yang J, Xu L, Zhang C,. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol. 2012; 52 (1): 245-255.
37. Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010; 39 (1): 133-144.
38. Devaux Y, Vausort M, McCann GP, et al. MicroRNA-150: a novel marker of left ventricular remodeling after acute myocardial infarction. Circ Cardiovasc Genet. 2013; 6 (3): 290-298.
39. Rhodes CJ, Wharton J, Boon RA, et al. Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013; 187 (3): 294-302.
40. Winbanks CE, Beyer C, Hagg A, Qian H, Sepulveda PV, Gregorevic P,. miR-206 represses hypertrophy of myogenic cells but not muscle fibers via inhibition of HDAC4. PLoS One. 2013; 8 (9): e73589.
41. Georgantas RW, Streicher K, Greenberg SA, et al. Inhibition of myogenic microRNAs 1, 133, and 206 by inflammatory cytokines links inflammation and muscle degeneration in adult inflammatory myopathies. Arthritis Rheumatol. 2014; 66 (4): 1022-1033.
42. Boettger T, Braun T,. A new level of complexity: the role of microRNAs in cardiovascular development. Circ Res. 2012; 110 (7): 1000-1013.
43. Zordoky BN, El-Kadi AO,. H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart. J Pharmacol Toxicol Methods. 2007; 56 (3): 317-322.
44. Bao Y, Lin C, Ren J, Liu J,. MicroRNA-384-5p regulates ischemia-induced cardioprotection by targeting phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta (PI3 K p110delta). Apoptosis. 2013; 18 (3): 260-270.
45. Su M, Wang J, Wang C, et al. MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ. 2015; 22 (6): 986-999.